Relay Therapeutics Inc
Biotechnology
Healthcare
RLAY
171 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.60
52 week high
9.51
high
4.66
52 week low
0.00
previous Close
4.54
P/E ratio
market cap
631 M
div yield
0
net incoming
-70.38 M
8.68 %
net profit margin
-10395.13 %
-9391.00 %
operating incoming
-76.85 M
9.45 %
net change in cash
20.54 M
166.80 %
cash on hand
114 M
21.81 %
cost of revenue
1.00 M
0.00 %
top